Updated: January 14, 2026
How to Help Your Patients Save Money on Suflave: A Provider's Guide to Savings Programs
Author
Peter Daggett

- Understanding Suflave's Cost Landscape
- Savings Option 1: Azurity Pharmaceuticals Savings Card
- Savings Option 2: GoodRx and Prescription Discount Cards
- Savings Option 3: Insurance Coverage Optimization
- When to Prescribe a Lower-Cost Alternative Instead
- Practical Implementation: Adding Cost Counseling to Your Prep Workflow
- Helping Patients Find Suflave and Alternatives at Pharmacies
- The Bottom Line
Overview
A provider's guide to Suflave savings programs, manufacturer copay cards, GoodRx, insurance strategies, and low-cost alternatives to keep patients from skipping their colonoscopy due to cost.
Is Suflave in stock near you?
Based on 64 real pharmacy checks · 1 patients helped
Verified 5h ago
Colonoscopy prep cost is a real barrier for many patients. At a retail price of $134–$170, Suflave (polyethylene glycol 3350, sodium sulfate, potassium chloride, magnesium sulfate, and sodium chloride) can be a meaningful expense for patients who are underinsured, uninsured, or have high-deductible insurance plans. When patients can't afford their prep, they delay or skip their colonoscopy — which has serious long-term health consequences.
This guide gives GI providers and prescribers a comprehensive overview of Suflave savings programs, insurance strategies, and alternative options to help every patient complete their pre-colonoscopy prep regardless of financial circumstances.
Understanding Suflave's Cost Landscape
Suflave is a brand-name-only product with no generic equivalent. This creates a distinctive cost profile:
- Retail price: $134–$170 per kit (1 complete prep = 2 bottles + 2 flavor packets)
- Insurance tier: Typically Tier 3 or Tier 4 on commercial formularies
- Prior authorization: Required by some commercial plans; step therapy may require failure of a generic alternative first
- Generic comparison: GoLYTELY (generic PEG) costs $10–$40 and is covered by virtually all insurance plans including Medicare and Medicaid
Check live stock now.
Savings Option 1: Azurity Pharmaceuticals Savings Card
Azurity Pharmaceuticals offers a savings card for Suflave for eligible commercially insured patients. The program structure:
- Patient pays the first $50 of the copay
- The manufacturer covers the remainder up to the program maximum through Capital Rx
- Available for commercially insured patients both with and without Suflave product coverage
- NOT available for Medicare, Medicaid, or other federal or state programs
Provider action: Point patients to suflave.com/savings or provide the savings card in your prep instruction packet. Your pharmacist can also submit it directly through Capital Rx.
Savings Option 2: GoodRx and Prescription Discount Cards
For patients who are uninsured or whose insurance does not cover Suflave, prescription discount programs can offer meaningful savings:
- GoodRx: Reduces Suflave to approximately $101.81 — a savings of about 35% off retail price of $157.44
- SingleCare: Offers Suflave at approximately $127.92
Patients should compare their insurance copay with GoodRx and use whichever is lower. These discount cards cannot be combined with insurance at the same time.
Savings Option 3: Insurance Coverage Optimization
Help your patients navigate their insurance more effectively:
- Preventive vs. diagnostic distinction: Under the ACA, colonoscopy for screening purposes is a covered preventive service with no cost-sharing for in-network providers. The prep medication is part of the procedure. Some plans cover it under Part B (medical benefit) rather than Part D (pharmacy benefit), which may eliminate the copay entirely.
- Prior authorization support: If a patient's plan requires PA for Suflave, your office can expedite the process by including clinical documentation of palatability needs (e.g., prior GI intolerance, history of incomplete prep with other agents).
- Step therapy exceptions: For patients whose plan requires trying GoLYTELY first, document clinical justification for Suflave (patient history of poor prep compliance, swallowing concerns, IBS with large-volume sensitivity).
When to Prescribe a Lower-Cost Alternative Instead
When cost is the primary barrier to obtaining Suflave, prescribing a more affordable alternative may be the best patient-centered decision. A colonoscopy with a lower-cost prep is infinitely better than a missed colonoscopy:
- GoLYTELY/NuLYTELY (generic PEG): $10–$40, covered by Medicare/Medicaid, virtually every pharmacy; 4-liter volume is the tradeoff
- SUPREP (generic sulfate prep): Generic versions $30–$60; similar sulfate mechanism to Suflave; widely covered
- SUTAB: $75–$150 without insurance; tablet-based — preferred for patients with swallowing concerns about large volumes
Practical Implementation: Adding Cost Counseling to Your Prep Workflow
Consider adding a brief cost check to your colonoscopy prep scheduling workflow:
- At scheduling: Ask "Do you have insurance that covers prescription medications?"
- If uninsured/underinsured: Route to generic GoLYTELY or provide GoodRx coupon information for Suflave ($101.81)
- If commercially insured: Include the Azurity savings card in the prep packet
- If Medicare/Medicaid: Prescribe GoLYTELY (covered, $0–$10) or check Part D formulary for covered preps
Found
Rate
on average
Helping Patients Find Suflave and Alternatives at Pharmacies
When patients have trouble finding Suflave at a pharmacy near them, medfinder can help. Patients enter their medication and location, and medfinder calls pharmacies to check availability and texts results. Learn more at medfinder.com/providers.
The Bottom Line
Cost should never be the reason a patient skips their colonoscopy. By understanding Suflave's savings programs, pointing commercially insured patients to the manufacturer savings card, providing GoodRx coupon information, and having a low-cost alternative ready for Medicare/Medicaid patients, GI practices can dramatically reduce cost-related prep failures and ensure patients complete their potentially life-saving colorectal cancer screening.
Real-time availability
Is Suflave in stock near you?
Verified 5h ago
Based on 64 real pharmacy checks · 1 patients helped
Suflave is in a shortage right now — Medfinder calls pharmacies near you to track down the ones that have it.
As of July 21, 2026, 2:00 PM ET, Suflave is currently experiencing a shortage. Across 64 pharmacy checks Medfinder placed in the last 30 days, Suflave was confirmed in stock 2% of the time.
- Pharmacy checks
- 64
- FDA status
- Not listed
- Updated
- 5h ago
Suflave is not on the FDA's active shortage list. Medfinder's own pharmacy calls put real-time availability at 2% across 64 checks in the last 30 days. Availability varies by metro, with the most pharmacy activity recorded around Chicago, IL. These numbers are recomputed continuously from live pharmacy calls, so this page reflects current conditions rather than a static estimate.
Suflave availability questions
Is Suflave in stock right now?
As of July 21, 2026, 2:00 PM ET, Suflave was confirmed in stock at 2% of 64 pharmacies Medfinder checked in the last 30 days. Availability changes daily, so we re-check in real time when you search.
How does Medfinder help me find Suflave?
Medfinder calls pharmacies in your area to verify whether Suflave and your specific dose are in stock, then sends you the pharmacy name, address, and phone number.
Need Suflave? We'll find the pharmacy that has it.
Sources: FDA Drug Shortages + Medfinder pharmacy data · Methodology · Full Suflave data
Frequently Asked Questions
As of 2026, Azurity Pharmaceuticals offers a savings card program for commercially insured patients (not valid for Medicare or Medicaid), where the patient pays the first $50 and the manufacturer covers the remainder up to the program maximum. A formal low-income patient assistance program (PAP) offering free medication has not been widely reported. For Medicare/Medicaid patients, prescribing a covered generic alternative like GoLYTELY may be the most practical solution.
Medicare coverage for Suflave depends on the specific Part D formulary. If the colonoscopy is for preventive screening and falls under Medicare Part B coverage, the prep may be covered under the medical benefit with no cost-sharing. However, if it falls under Part D pharmacy benefit coverage, there may be cost-sharing. The manufacturer savings card does not apply to Medicare patients. For Medicare patients, prescribing a covered generic prep (GoLYTELY) is often the most cost-effective solution.
Consider prescribing generic GoLYTELY (PEG-3350 with electrolytes) when: the patient is uninsured or underinsured with no savings card available, the patient has Medicare or Medicaid (where generic preps are covered at minimal cost), or the patient declines Suflave due to cost concerns even after being informed of discount options. GoLYTELY provides excellent efficacy at $10–$40 and is universally covered.
To initiate prior authorization for Suflave: have your office call the patient's insurance plan to request a PA form, submit clinical documentation including diagnosis codes (colonoscopy for screening/diagnosis), and document any clinical rationale for brand-name Suflave over generic alternatives (e.g., prior incomplete prep, GI intolerance to high-volume preps, improved palatability for prep-hesitant patients). Most commercial insurers process PAs within 24–72 hours.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Suflave also looked for:
More about Suflave
38,083 have already found their meds with Medfinder.
Start your search today.
Your information is private and never shared.





